Grant: CIHR Fellowship
McGill University
$135,000.00
Modeling changes in cervical cancer screening performance in the human papillomavirus (HPV) vaccine era and the determinants of HPV transmission
EF 2015-16
Résumé
Cytological screening is highly effective at preventing cervical cancer. However, the value of screening is less certain for the increasing number of women vaccinated against the human papillomavirus (HPV). A lower prevalence of carcinogenic HPV will reduce the performance of screening, with more false positives and overtreatment. Changes in screening practices are being considered to retain the preventive benefits while minimizing negative health outcomes. Using dynamic mathematical modelling, I will first simulate changes in screening performance, and assess the benefits of different protocol changes which may be considered such as increasing age at screening initiation, extending screening intervals, or targeting women at higher risk of cervical cancer. Dynamic models are the most rigorous method of evaluating uncertainty around potential long-term benefits and harms of health interventions. The results will be highly valuable for policy-makers seeking to provide evidence-based recommendations for cervical screening.
Individuals with multiple HPV infections are at higher risk of developing cervical precancer. Sexual behaviour, acquired immunity, and genetic predisposition contribute to individuals' infection risk, but it is difficult in epidemiological studies to determine the relative importance of each factor due to measurement error and confounding. My second objective is to develop dynamic models of HPV transmission calibrated to data from a biobank of over 40,000 biological samples collected in epidemiological studies (HITCH, McGill-Concordia, Ludwig-McGill, CCCaST) to evaluate the relative importance of sexual behaviour and acquired immunity for HPV transmission, and analyze whether epidemiological observations are consistent with our understanding of HPV natural history. This research will identify the most important determinants of infection, which will help understand inter-individual variation in the efficacy of HPV vaccination and screening.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
338716
Name
Malagon Talia C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Modeling changes in cervical cancer screening performance in the human papillomavirus (HPV) vaccine era and the determinants of HPV transmission
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cervical Cancer; Cervical Cancer Screening; Epidemiology; Hpv Vaccination; Human Papillomavirus; Infection Risk Factors; Mathematical Modelling; Transmission
Abstract
Cytological screening is highly effective at preventing cervical cancer. However, the value of screening is less certain for the increasing number of women vaccinated against the human papillomavirus (HPV). A lower prevalence of carcinogenic HPV will reduce the performance of screening, with more false positives and overtreatment. Changes in screening practices are being considered to retain the preventive benefits while minimizing negative health outcomes. Using dynamic mathematical modelling, I will first simulate changes in screening performance, and assess the benefits of different protocol changes which may be considered such as increasing age at screening initiation, extending screening intervals, or targeting women at higher risk of cervical cancer. Dynamic models are the most rigorous method of evaluating uncertainty around potential long-term benefits and harms of health interventions. The results will be highly valuable for policy-makers seeking to provide evidence-based recommendations for cervical screening.
Individuals with multiple HPV infections are at higher risk of developing cervical precancer. Sexual behaviour, acquired immunity, and genetic predisposition contribute to individuals' infection risk, but it is difficult in epidemiological studies to determine the relative importance of each factor due to measurement error and confounding. My second objective is to develop dynamic models of HPV transmission calibrated to data from a biobank of over 40,000 biological samples collected in epidemiological studies (HITCH, McGill-Concordia, Ludwig-McGill, CCCaST) to evaluate the relative importance of sexual behaviour and acquired immunity for HPV transmission, and analyze whether epidemiological observations are consistent with our understanding of HPV natural history. This research will identify the most important determinants of infection, which will help understand inter-individual variation in the efficacy of HPV vaccination and screening.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Malagon, Talia C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~